Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Executive Summary
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
You may also be interested in...
Qiagen Ready To Rival Abbott With Rapid, Portable Antigen COVID-19 Test
The diagnostics company said the test is scheduled for US launch in Q4 2020.
Qiagen Terminates Thermo Fisher Deal After Shareholders Reject Last Offer
Qiagen's shareholders said Thermo Fisher's final offer price for the diagnostics company was too low.
California Federal Court Rejects Settlement Proposal In Coppertone ‘Mineral-Based’ Sunscreen Case
Beiersdorf and former owner Bayer are on the verge of settling a proposed class action in California’s Northern District challenging “mineral-based” claims on Coppertone sunscreens that also contain chemical UV filters. However, the parties will have to try again with their proposed terms.